ALS Research Collaboration
  • Home
  • About Us
    • Who we are
    • Our Approach
    • Our Team
    • Our History
  • Our Research
    • Research Focus
    • Participate
    • Studies
    • Current
    • Completed
    • All
    • Publications & Talks
    • Research Vignettes
  • News & Events
  • Support Us
    • Make a donation
  • Contact Us
Select Page

Strategies for pre-symptomatic biomarker identification in familial ALS.

by admin | Jun 1, 2022

Benatar M (invited speaker). Strategies for pre-symptomatic biomarker identification in familial ALS. Cold Spring Harbor Symposium on Drug Discovery, Biomarkers, and Clinical Trials for ALS. Banbury Center, Cold Spring Harbor, NY, September 2007. [PubMed...

Predictive, Preventive and Therapeutic Studies in Familial ALS.

by admin | Jun 1, 2022

Benatar M (invited speaker). Predictive, Preventive and Therapeutic Studies in Familial ALS. ALS Association Annual Leadership Forum. Orange County, CA, January 2008. [PubMed Link]

Frequency, hazard, and genetic risk factors of cognitive impairment in amyotrophic lateral sclerosis (ALS).

by admin | Jun 1, 2022

McMillan CT (presenter), Wuu J, Hennessy L, Placek K, Clinical Research in ALS (CRiALS) Study, Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, Canadian ALS Neuroimaging Consortium (CALSNIC), Quinn C, Elman L, Grossman M,...

Design of a phase 3, randomized, placebo-controlled trial of tofersen initiated in clinically presymptomatic SOD1 mutation carriers: The ATLAS Study

by Alexandra Grace | Jun 1, 2022

Benatar M (presenter), Wuu J, Andersen PM, Andrews J, Bucelli RC, Otto M, Ferguson TA, Chen W, Fanning L, Graham D, Sun P, Liu Y, Wong J, Fradette S. Design of a phase 3, randomized, placebo-controlled trial of tofersen initiated in clinically presymptomatic SOD1...

Randomized Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS.

by admin | Mar 25, 2022

Benatar M (invited speaker). Randomized Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS. ALS Association Drug Discovery Symposium. Seattle, WA, May 2009. [PubMed Link]
« Older Entries
Next Entries »

Recent Posts

  • Landmark Study Identifies Novel Pre-Symptomatic Biomarkers and Accelerates Progress Towards ALS Prevention
  • July 26, 2026: Miami Marlins Game
  • Feature: UHealth’s Qalsody Clinic Provides Cutting-Edge Care for ALS Patients
  • The New York Times Feature: In a Milestone for A.L.S., a Treatment Helps Some Patients Improve
  • CReATe Author Series Ep. 18 – Dr. Michael Benatar on MMI as a prodromal stage of ALS

Recent Comments

    Latest News

    07/27/26

    Landmark Study Identifies Novel Pre-Symptomatic Biomarkers and Accelerates Progress Towards ALS Prevention

    07/22/26

    July 26, 2026: Miami Marlins Game

    05/26/26

    Feature: UHealth’s Qalsody Clinic Provides Cutting-Edge Care for ALS Patients

    How You Can Help

    Participate in Research

    Make a Donation

    ALS Research Collaboration
    University of Miami,
    Department of Neurology
    1120 NW 14th Street
    Miami, FL 33136

    Search our site

    About Us

    • Who We Are
    • Our Approach
    • Our Team
    • Our History

    Our Research

    • Research Focus
    • Participate
    • All Studies
    • Publications and Talks
    • Research Vignettes

    Support Us

    • Make a Donation

    Search our site

    Copyright 2024 ALS Research Collaboration at University of Miami. All Rights Reserved. Branding by MOK2